propranolol and Diabetic Cardiomyopathies
propranolol has been researched along with Diabetic Cardiomyopathies in 2 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Diabetic Cardiomyopathies: Diabetes complications in which VENTRICULAR REMODELING in the absence of CORONARY ATHEROSCLEROSIS and hypertension results in cardiac dysfunctions, typically LEFT VENTRICULAR DYSFUNCTION. The changes also result in myocardial hypertrophy, myocardial necrosis and fibrosis, and collagen deposition due to impaired glucose tolerance.
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
"Propranolol treatment normalized also the prolongation of the action potential in papillary muscles from the diabetic rat hearts." | 1.37 | Cardioprotective effect of propranolol on diabetes-induced altered intracellular Ca2+ signaling in rat. ( Tuncay, E; Turan, B; Zeydanli, EN, 2011) |
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Jungen, C | 1 |
Scherschel, K | 1 |
Flenner, F | 1 |
Jee, H | 1 |
Rajendran, P | 1 |
De Jong, KA | 1 |
Nikolaev, V | 1 |
Meyer, C | 1 |
Ardell, JL | 1 |
Tompkins, JD | 1 |
Tuncay, E | 1 |
Zeydanli, EN | 1 |
Turan, B | 1 |
Other Studies
2 other studies available for propranolol and Diabetic Cardiomyopathies
Article | Year |
---|---|
Increased arrhythmia susceptibility in type 2 diabetic mice related to dysregulation of ventricular sympathetic innervation.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Signaling; Diabetic Cardiomyopathies; | 2019 |
Cardioprotective effect of propranolol on diabetes-induced altered intracellular Ca2+ signaling in rat.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Antibiotics, Antineoplastic; Calcium Signaling; | 2011 |